All together, we suggest that, in order to enhance antitumor responses, current HNSCC research should focus on the modulation of the TIME to support infiltration of tumor-associated NK cells and CD8+ T cells. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.